Analytical validation of the tag-it high-throughput microsphere-based universal array genotyping platform: Application to the multiplex detection of a panel of thrombophilia-associated single-nucleotide polymorphisms

被引:57
作者
Bortolin, S
Black, M
Modi, H
Boszko, I
Kobler, D
Fieldhouse, D
Lopes, E
Lacroix, JM
Grimwood, R
Wells, P
Janeczko, R
Zastawny, R
机构
[1] Tm Biosci Corp, Toronto, ON M5G 1Y8, Canada
[2] Univ Ottawa, Div Hematol, Dept Med, Ottawa Hlth Res Inst, Ottawa, ON, Canada
关键词
D O I
10.1373/clinchem.2004.035071
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: We have developed a novel, microsphere-based universal array platform referred to as the Tag-It(TM) platform. This platform is suitable for high-throughput clinical genotyping applications and was used for multiplex analysis of a panel of thrombophilia-associated single-nucleotide polymorphisms (SNPs). Methods: Genomic DNA from 132 patients was amplified by multiplex PCR using 6 primer sets, followed by multiplex allele-specific primer extension using 12 universally tagged genotyping primers. The products were then sorted on the Tag-It array and detected by use of the Luminex xMAP(TM) system. Genotypes were also determined by sequencing. Results: Empirical validation of the universal array showed that the highest nonspecific signal was 3.7% of the specific signal. Patient genotypes showed 100% concordance with direct DNA sequencing data for 736 SNP determinations. Conclusions: The Tag-It microsphere-based universal array platform is a highly accurate, multiplexed, high-throughput SNP-detection platform. (C) 2004 American Association for Clinical Chemistry.
引用
收藏
页码:2028 / 2036
页数:9
相关论文
共 31 条
[1]   The thrombophilias: Well-defined risk factors with uncertain therapeutic implications [J].
Bauer, KA .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (05) :367-373
[2]   Venous thrombosis - The interaction of genes and environment [J].
Bertina, RM ;
Rosendaal, FR .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (25) :1840-1841
[3]  
Bertina RM, 1997, CLIN CHEM, V43, P1678
[4]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[5]  
Dunbar SA, 2000, CLIN CHEM, V46, P1498
[6]   Evaluation of electronic microarrays for genotyping factor V, factor II, and MTHFR [J].
Erali, M ;
Schmidt, B ;
Lyon, E ;
Wittwer, C .
CLINICAL CHEMISTRY, 2003, 49 (05) :732-739
[7]   The C536T transition in the tissue factor pathway inhibitor gene is not a common cause of venous thromboembolic disease in the UK population [J].
Evans, GD ;
Langdown, J ;
Brown, K ;
Baglin, TP .
THROMBOSIS AND HAEMOSTASIS, 2000, 83 (03) :511-511
[8]  
Evans JG, 2002, CLIN CHEM, V48, P1406
[9]   A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease [J].
Franco, RF ;
Morelli, V ;
Lourenço, D ;
Maffei, FH ;
Tavella, MH ;
Piccinato, CE ;
Thomazini, IA ;
Zago, MA .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 (02) :556-559
[10]  
Franco RF, 1999, THROMB HAEMOSTASIS, V81, P676